top of page
BPIQ Blog
Aug 1, 20221 min read
Biopharma Mid Morning Pulse - 08/01/22
(Posted 10:20am CST) $XBI $80.99 | -0.17% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Aug 1, 20221 min read
Free Biopharma Mid Morning Pulse - 08/01/22
(Posted 10:20am CST) $XBI $80.99 | -0.17% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jun 7, 20222 min read
Biopharma Daily Stock Updates - 06/07/22
$XBI $72.60 | +4.94% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX 0.0% (+22% AH) Novavax...
Jun 7, 20222 min read
Free Biopharma Daily Stock Updates - 06/07/22
$XBI $72.60 | +4.94% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX 0.0% (+22% AH) Novavax...
Jun 6, 20224 min read
Biopharma Daily Stock Updates - 06/06/22
$XBI $69.18 | -2.85% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates # Pipeline Updates #CYCN +8.6%...
Jun 6, 20224 min read
Free Biopharma Daily Stock Updates - 06/06/22
$XBI $69.18 | -2.85% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates # Pipeline Updates #CYCN +8.6%...
Jun 3, 20223 min read
Biopharma Pulse - 5/30-6/3 Week in Review
As we begin June, we review moves from smid-cap biopharma companies during this past week as well as in May. See Table 1 for weekly...
May 31, 20222 min read
Biopharma Daily Pulse - 05/31/22 (Subscribers)
$XBI $68.78 | -3.25% BPIQ median | -1.84% Big Positive Movers on News #TXMD +364% TherapeuticsMD and EW Healthcare Partners Announce...
May 31, 20222 min read
Biopharma Daily Pulse - 05/31/22 (Free Blog)
$XBI $68.78 | -3.25% BPIQ median | -1.84% Big Positive Movers on News #TXMD +364% TherapeuticsMD and EW Healthcare Partners Announce...
Apr 8, 201910 min read
Incyte (INCY) appears to have the stronger hand in its patent disputes with Concert (CNCE), regardle
BIopharma companies (Concert and Incyte) patent dispute.
Apr 8, 20197 min read
Incyte (INCY) appears to have the stronger hand in its patent disputes with Concert (CNCE), regardle
(For a longer version of this article, with more detailed legal facts, please CLICK HERE.) Concert (CNCE) and Incyte (INCY) have been...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page